AWR vs CWT

AWR exhibits stable financial health with a Piotroski F-Score of 6/9, indicating moderate strength, though the absence of an Altman Z-Score limits distress risk assessment. The stock appears fairly valued with a current price of $73.16 near the analyst target of $81.00 and intrinsic value estimate of $81.76, despite trading above the conservative Graham Number of $44.06. Solid profitability metrics—such as a 33.96% operating margin and 13.78% ROE—contrast with a bearish technical trend and weak insider sentiment. Revenue and earnings growth remain positive year-over-year, but recent quarterly volatility and limited analyst coverage warrant caution.

CWT exhibits significant valuation misalignment, trading at $46.38 despite a Graham Number of $37.02 and a growth-based intrinsic value of $15.05. The Piotroski F-Score of 4/9 indicates only stable health, while severe earnings contraction (-42.20% YoY) and negative revenue growth suggest fundamental decay. Despite a 'Strong Buy' analyst consensus, the combination of bearish insider selling, a 0/100 technical trend, and poor liquidity (Current Ratio 0.85) points to a bearish outlook.